Skip to main content
. 2015 Nov;3(19):284. doi: 10.3978/j.issn.2305-5839.2015.11.14

Table 4. Treatment modification for both groups.

Modifications Group 1 (cycle numbers)
 Group 2 (cycle numbers)
 P value
FEC-100 Taxotere 80 carboplatin FEC-100 Taxotere 100
Treatment discontinuation 0 22 0 18 0.08
Treatment delay 5 15 6 11 0.09
Dose reduction 21 73 20 55 0.04